“…Currently, anticonvulsant drugs are commonly used to control symptoms in neuropathic pain, especially for their ability to reduce neuronal excitability by acting through different mechanisms (Attal et al, 2010;Delzell and Grelle, 1999;Finnerup et al, 2010aFinnerup et al, , 2010bGill et al, 2011;Martin and Forouzanfar, 2011;Willimann, 2011;Zakrzewska and McMillan, 2011). The most studied agents are carbamazepine, gabapentin and pregabalin, but lamotrigine, topiramate and oxcarbazepine have also shown analgesic potential in different pain models and in clinical studies (Ambrósio et al, 2002;Cheng and Chiou, 2006;Cheshire, 2002;Czapinski et al, 2005;Lynch and Watson, 2006;Siniscalchi et al, 2011;Wilhelmus and Forouzanfar, 2011). Indeed, carbamazepine is currently the first choice for treatment of trigeminal neuralgia, as it has been shown to reduce pain symptoms in about 70% of the cases, and it is also used to diagnose the condition (Ambrósio et al, 2002;Kleef et al, 2009).…”